D. Dias e Silva

Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report

Pedro Luiz Serrano Uson Junior, G. Botrus, Akemi Osawa, 2023, International journal of molecular sciences.

Antibody-Drug Conjugates and Tissue-Agnostic Drug Development

R. Pestana, Douglas Dias e Silva, Guilherme Malandrini Andriatte, 2022, Cancer journal.

Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival? A systematic review and meta-analysis of randomized controlled trials

E. T. Rother, M. Borad, Pedro Luiz Serrano Uson Junior, 2023, ESMO open.